If You Invested $10,000 In AbbVie Stock 10 Years Ago, How Much Would You Have Now?
AbbVie Inc. (NYSE:ABBV) discovers, develops, manufactures and sells pharmaceuticals worldwide. It is set to report the Q4 ...
AbbVie Q4 2024 Earnings Preview: Strong results expected on Skyrizi, Rinvoq growth trajectory
AbbVie (ABBV) is expected to beat Q4 earnings estimates with strong performance from key products, including Skyrizi and Rinvoq.
AbbVie's SWOT analysis: biopharmaceutical giant navigates post-Humira landscape
AbbVie (NYSE:ABBV) continues to navigate the challenges of Humira's loss of exclusivity while leveraging its diverse portfolio and robust pipeline to drive future growth. With a gross profit margin of ...
Inside Track: Why Relentless Self-Promoters Need Not Apply for GC Posts
True leadership is about putting others first,” said Jason B. Daly, chief legal officer of Amneal Pharmaceuticals.
Zacks.com on MSN3h
IRWD Begins Apraglutide NDA Submission, Announces Job Cuts, Stock Falls
Ironwood Pharmaceuticals, Inc. IRWD announced that it has initiated the rolling new drug application (“NDA”) submission for ...
BioSpace4h
Chicago Area’s Life Sciences Scene Continues Making an Impression
While the Chicago metropolitan area is not a major life sciences hub, a recent Cushman & Wakefield report predicts the Chicago market should be a growth spot in the coming years. Chicago Biomedical ...
Peninsula biotech moves from IPO to chopping half its workforce in little more than a year
After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...
con-telegraph.ie22h
Mayo LGFA and AbbVie unite for groundbreaking player wellness initiative
Mayo Ladies Gaelic Football Association (LGFA) has announced a dynamic new partnership with global biopharmaceutical leader ...